Abstract
Background: Image segmentation plays a vital role in clinical study and in diagnosing the stages of diseases. The hospitals are marching towards filmless imaging process in par with digital film technology.
Materials and Methods: The paper proposes a novel method based on morphometric segmentation algorithm with Region of Interest (ROI). The core objective is to detect better segmentation of a brain tumor from an MRI image for a clinical study.
Results and Conclusion: A set of experiment has been performed for the analysis of the proposed work on several MRI images. The proposed morphometric segmentation method provides better accuracy on segmentation of tumor image from the input MRI image.
Keywords: Brain tumor, pre-processing, segmentation, region of interest, statistical region merging, thresholding, graph cut segmentation.
Current Signal Transduction Therapy
Title:Automated Brain Tumor Segmentation from MRI Images using Morphometric Algorithms
Volume: 15 Issue: 3
Author(s): C. Senthilkumar*R.K. Gnanamurthy
Affiliation:
- Dr. N.G.P. Institute of Technology, Coimbatore, Coimbatore, 641048, Tamil Nadu,India
Keywords: Brain tumor, pre-processing, segmentation, region of interest, statistical region merging, thresholding, graph cut segmentation.
Abstract:
Background: Image segmentation plays a vital role in clinical study and in diagnosing the stages of diseases. The hospitals are marching towards filmless imaging process in par with digital film technology.
Materials and Methods: The paper proposes a novel method based on morphometric segmentation algorithm with Region of Interest (ROI). The core objective is to detect better segmentation of a brain tumor from an MRI image for a clinical study.
Results and Conclusion: A set of experiment has been performed for the analysis of the proposed work on several MRI images. The proposed morphometric segmentation method provides better accuracy on segmentation of tumor image from the input MRI image.
Export Options
About this article
Cite this article as:
Senthilkumar C. *, Gnanamurthy R.K. , Automated Brain Tumor Segmentation from MRI Images using Morphometric Algorithms, Current Signal Transduction Therapy 2020; 15 (3) . https://dx.doi.org/10.2174/1574362414666190808090823
DOI https://dx.doi.org/10.2174/1574362414666190808090823 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypericin - A New Antiviral and Antitumor Photosensitizer: Mechanism of Action and Interaction with Biological Macromolecules
Current Drug Targets OIP5-AS1: A Fascinating Long Noncoding RNA in Carcinoma
Current Pharmaceutical Design RNA Splicing: Basic Aspects Underlie Antitumor Targeting
Recent Patents on Anti-Cancer Drug Discovery Radiation-Induced Stress Proteins - the Role of Heat Shock Proteins (HSP) in Anti- Tumor Responses
Current Medicinal Chemistry Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics
Current Cancer Drug Targets Liquid Crystal Nanodispersions Enable the Cutaneous Delivery of Photosensitizer for Topical PDT: Fluorescence Microscopy Study of Skin Penetration
Current Nanoscience Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
Current Medicinal Chemistry Pharmacology of Sigma (σ) Receptor Ligands from a Behavioral Perspective
Current Pharmaceutical Design Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment
Clinical Cancer Drugs Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Thioredoxin, Glutathione and Related Molecules in Tumors of the Nervous System
Current Medicinal Chemistry Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke
Current Pharmaceutical Design Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Connexin Genes as Promising Therapeutic Targets in Cancers
Current Pharmacogenomics Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Non-Covalent Proteasome Inhibitors
Current Pharmaceutical Design Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery